Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study.

Yasuhiro TsutaniYoshihiro MiyataTakeshi MasudaKazunori FujitakaMihoko DoiYoshikazu AwayaShoichi KuyamaSoichi KitaguchiKazuhiro UedaNoboru HattoriMorihito Okada

Published in: BMC cancer (2018)

UMIN Clinical Trial Registry: UMIN000005569 . Registered date: May 8, 2011.

Keyphrases

phase ii study
small cell lung cancer
clinical trial
open label
advanced non small cell lung cancer
metastatic colorectal cancer
locally advanced
double blind
phase ii
radiation therapy
phase iii
high density